pembrolizumab,sunitinib,axitinib
pfizer,merck
['keynote-426', 'key,note,426', 'rcc,(-irccs),(-srcc),(-urcc)']
dr. brian rini discusses the keynote-426 trial in advanced rcc. #urology #urologist #kidneycancer #asco23 
The Leading News Source for Urologists - https://t.co/hDKngB4IyE
Expert clinical analysis. Practice advice. Policy perspectives.